BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14646598)

  • 1. CD99 type II is a determining factor for the differentiation of primitive neuroectodermal cells.
    Lee EJ; Lee HG; Park SH; Choi EY; Park SH
    Exp Mol Med; 2003 Oct; 35(5):438-47. PubMed ID: 14646598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD99 isoforms expression dictates T cell functional outcomes.
    Alberti I; Bernard G; Rouquette-Jazdanian AK; Pelassy C; Pourtein M; Aussel C; Bernard A
    FASEB J; 2002 Dec; 16(14):1946-8. PubMed ID: 12368226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
    Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
    Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cyclophilin A as a CD99-binding protein by yeast two-hybrid screening.
    Kim HJ; Chong KH; Kang SW; Lee JR; Kim JY; Hahn MJ; Kim TJ
    Immunol Lett; 2004 Sep; 95(2):155-9. PubMed ID: 15388255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the dimerization of human CD99 using bimolecular fluorescence complementation technique.
    Lee MK; Kim HS; Kim SS; Cho MH; Lee IS
    J Microbiol Biotechnol; 2008 Mar; 18(3):472-6. PubMed ID: 18388464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of mic2/CD99 gene vector and its transfection in Hodgkin lymphoma L428 cell line].
    Huang ZP; He Y; Zhou XH; Han XQ; Wu ZQ; Zhang Y; Wen ZH; Zhao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2407-9. PubMed ID: 20034888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial primitive neuroectodermal tumor/Ewing sarcoma (PN/ES): same tumor as deep PN/ES or new entity?
    Ehrig T; Billings SD; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Jun; 11(3):153-9. PubMed ID: 17498589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.
    Gazit R; Rechnitzer H; Achdout H; Katzenell A; Katz G; Markel G; Arnon TI; Gonen-Gross T; Mizrahi S; Gruda R; Rottem S; Mandelboim O
    Eur J Immunol; 2004 Jul; 34(7):2032-40. PubMed ID: 15214051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response.
    Schenkel AR; Dufour EM; Chew TW; Sorg E; Muller WA
    Cell Commun Adhes; 2007; 14(5):227-37. PubMed ID: 18163232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity of CD99 in stomach cancer.
    Jung KC; Park WS; Bae YM; Hahn JH; Hahn K; Lee H; Lee HW; Koo HJ; Shin HJ; Shin HS; Park YE; Park SH
    J Korean Med Sci; 2002 Aug; 17(4):483-9. PubMed ID: 12172043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.
    Oranger A; Brunetti G; Carbone C; Colaianni G; Mongelli T; Gigante I; Tamma R; Mori G; Di Benedetto A; Sciandra M; Ventura S; Scotlandi K; Colucci S; Grano M
    J Immunol Res; 2015; 2015():156787. PubMed ID: 26000312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 regulates CXCL12-induced chemotaxis of human plasma cells.
    Gil M; Pak HK; Lee AN; Park SJ; Lee Y; Roh J; Lee H; Chung YS; Park CS
    Immunol Lett; 2015 Dec; 168(2):329-36. PubMed ID: 26522646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.
    Jian W; Zhong L; Wen J; Tang Y; Qiu B; Wu Z; Yan J; Zhou X; Zhao T
    PLoS One; 2015; 10(5):e0127568. PubMed ID: 26000982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.
    Hahn JH; Kim MK; Choi EY; Kim SH; Sohn HW; Ham DI; Chung DH; Kim TJ; Lee WJ; Park CK; Ree HJ; Park SH
    J Immunol; 1997 Sep; 159(5):2250-8. PubMed ID: 9278313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD99 acts as an oncosuppressor in osteosarcoma.
    Manara MC; Bernard G; Lollini PL; Nanni P; Zuntini M; Landuzzi L; Benini S; Lattanzi G; Sciandra M; Serra M; Colombo MP; Bernard A; Picci P; Scotlandi K
    Mol Biol Cell; 2006 Apr; 17(4):1910-21. PubMed ID: 16421247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
    Smolich BD; Papkoff J
    Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
    Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
    Oncogene; 2007 Oct; 26(46):6604-18. PubMed ID: 17471235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes.
    Choi EY; Park WS; Jung KC; Kim SH; Kim YY; Lee WJ; Park SH
    J Immunol; 1998 Jul; 161(2):749-54. PubMed ID: 9670951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of CD99 down-regulation in gastric adenocarcinoma.
    Lee JH; Kim SH; Wang LH; Choi YL; Kim YC; Kim JH; Park TS; Hong YC; Shin YK
    Clin Cancer Res; 2007 May; 13(9):2584-91. PubMed ID: 17473187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis.
    Gordon MD; Corless C; Renshaw AA; Beckstead J
    Mod Pathol; 1998 Aug; 11(8):769-73. PubMed ID: 9720506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.